StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3045% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Invivyd enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Invivyd's enterprise value was $16.57M on Nov 11, 2026, against $436.05M a year earlier. Over the last 5 years it ranged from -$225.38M to $444.62M, with a median of $37.69M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$16.57M-96.3%
2025Dec 31, 2025$444.62M–
2024Dec 31, 2024-$53.87M-121.5%
2023Dec 29, 2023$250.97M–
2022Dec 30, 2022-$114.72M-134.8%
2021Dec 31, 2021$329.42M–

More Invivyd figures

See a number that looks wrong?